Enanta Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2013
Total Assets: $117.0M
Liabilities Breakdown FY2013
Total Liabilities: $6.5M
Asset Breakdown
Total Assets: $117.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.9M | 7.6% |
| Accounts Receivable | $808.0K | 0.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $106.2M | 90.8% |
Liabilities Breakdown
Total Liabilities: $6.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 22.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.0M | 77.2% |